calcipotriene + tazarotene

Calcipotriene + tazarotene is a topical combination therapy used primarily for the treatment of plaque psoriasis. Calcipotriene is a synthetic vitamin D3 analog that regulates skin cell production and differentiation, while tazarotene is a third-generation topical retinoid (vitamin A derivative) that modulates gene expression to reduce keratinocyte proliferation and inflammation. The combination leverages complementary mechanisms—calcipotriene’s effects on cellular differentiation and proliferation, and tazarotene’s retinoid-mediated normalization of epidermal growth—to improve psoriatic lesions. Clinical studies have shown that using both agents together can be as effective as potent corticosteroids in reducing scaling, plaque elevation, and overall severity of psoriasis without significant chemical incompatibility or increased irritation[1].